Haleon (NYSE:HLN) Hits New 1-Year High - Time to Buy?

Haleon plc (NYSE:HLN - Get Free Report) hit a new 52-week high during trading on Monday . The stock traded as high as $11.42 and last traded at $11.42, with a volume of 14380083 shares trading hands. The stock had previously closed at $11.35.

Analyst Ratings Changes

A number of research firms have recently issued reports on HLN. Wall Street Zen cut Haleon from a "buy" rating to a "hold" rating in a research report on Thursday, May 22nd. HSBC reaffirmed a "hold" rating on shares of Haleon in a research report on Wednesday, March 5th. BNP Paribas Exane raised Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price objective for the company in a research report on Tuesday, May 27th. Hsbc Global Res cut Haleon from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, March 5th. Finally, Morgan Stanley upgraded Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 target price on the stock in a research note on Friday, May 9th. Six equities research analysts have rated the stock with a hold rating, four have issued a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $12.33.

Haleon Stock Performance

The company has a market cap of $50.06 billion, a P/E ratio of 32.74, a price-to-earnings-growth ratio of 2.82 and a beta of 0.31. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. The stock has a 50 day moving average price of $10.46 and a two-hundred day moving average price of $10.01.

Hedge Funds Weigh In On Haleon

A number of hedge funds have recently added to or reduced their stakes in the stock. Rhumbline Advisers increased its stake in Haleon by 6.7% during the 1st quarter. Rhumbline Advisers now owns 57,527 shares of the company's stock worth $592,000 after acquiring an additional 3,625 shares during the period. Acadian Asset Management LLC bought a new position in Haleon during the 1st quarter worth $1,767,000. Geneos Wealth Management Inc. increased its stake in Haleon by 33.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 4,846 shares of the company's stock worth $50,000 after acquiring an additional 1,203 shares during the period. Focus Partners Wealth increased its stake in Haleon by 7.6% during the 1st quarter. Focus Partners Wealth now owns 73,106 shares of the company's stock worth $752,000 after acquiring an additional 5,178 shares during the period. Finally, Ransom Advisory Ltd acquired a new stake in shares of Haleon in the 1st quarter valued at $31,000. Institutional investors own 6.67% of the company's stock.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.